Helicobacter pylori causes various diseases such as chronic gastritis, peptic ulcer and gastric cancer. While majority of the people infected with H. pylori is asymptomatic, 15-20 % of them develop such diseases. The main factors, which determine the development of H. pylori related diseases might be bacterial virulence, host genetic and environmental factors. The aim of this study was to reveal the factors that play a role in the disease development in patients with refl ux esophagitis and peptic ulcer, infected with Helicobacter pylori. Environmental factors such as medical agents, smoking and body mass index were evaluated. The factors specifi c to bacteria such as vacA, CagA, babA and iceA virulence genotypes and the host factors such as IL-1, IL-2, IL-4, IL-6, IL-10, IL-12, interferon-γ, TNF-α, ve TGF-β 1 gene polymorphisms were compared between the two groups. H. pylori infected twenty fi ve patients with refl ux esophagitis and peptic ulcer were enrolled in the study. There was no statistical difference between the two groups regarding environmental factors. IL-2 -330T +166T (p=0.037) and IL10 -1082A; -819C (p=0.049) gene polymorphisms were signifi cantly more common in the group of patients with peptic ulcer compared to the group with refl ux esophagitis. In both groups of patients, either with refl ux esophagitis or peptic ulcer, multiple H. pylori virulence genotypes (cagA, vacA, babA) (mean values 74 %, 78 %, 54 % respectively) were observed. In this study, we revealed that cytokine gene polymorphisms may play a role in the development peptic ulcer while H. pylori virulence genotypes seem to be crucial for the development of associated diseases (Tab. 4, Ref. 51). Text in PDF www.elis.sk.
Helicobacter pylori (H. pylori) infection is a gram-negative, microaerophilic bacteria which infects a majority of the world population (1) . The most important diseases caused by H. pylori are duodenum and gastric ulcer, gastric adenocarcinoma and primary gastric lymphoma (2) . In 1994, H. pylori was accepted as a 1st group carcinogen by the World Health Organization (3) .
The reason why Helicobacter pylori infection leads to different clinical results is not exactly known, but primarily three mechanisms are blamed for pathogenesis. These are host components such as genetic predisposition to the diseases and cytokine gene polymorphism which are said to affect the clinical results (4) , peripheral components such as smoking and food (5) (6) (7) , and virulence genotypes of Helicobacter pylori strain (8) . Evidences collected show that H. pylori infectious power has a high genetic heterogeneity, which results in the emergence of clinical sequelae (9) . It is though that principally four of the bacterial virulence genotypes that have been identifi ed are relevant with the clinical results. These are pore-forming toxin (vacA), cytokine-associated antigen (cagA), blood group antigen binding adhesin (babA) that allows H. Pylori to bind to Lewis b (a-1,3/4-difucosylated) blood group antigens in epithelial cells in the human stomach and iceA (induced by contact with epithelium). Virulence genotype called IceA is induced by the formation of a contact between H. pylori and human epithelial cells and was shown to be associated with peptic ulcer disease (10) . Strains producing VacA genotype were shown to be associated with increased gastric damage and peptic ulcer (11) . CagA positivity was identifi ed in higher rates in patients with peptic ulcer disease and gastric adenocarcinoma (12) (13) (14) .
The relation of H. pylori infection with gastroesophageal refl ux disease (GERD) is a very disputed subject due to suggested confl icting epidemiological data (15) (16) . One of the suggested hypotheses proposes that the suppression of acid release by corpus gastritis which is caused by H. pylori infection and the neutralization of the gastric acid by the ammonia which is produced by the bacterium are protective against the development of gastroesophageal refl ux. The studies, which support this view, reported a meaningful relationship between the absence of H. pylori infection and GERD symptoms (17) (18) . There are also publications stating that the development, relapse and symptoms of the gastroesophageal refl ux deteriorate with the eradication of H. pylori infection (19) (20) . In contrast with these studies, there are evidences that suggest no clinically signifi cant effect on GERD symptoms with the eradication of H. pylori infection (21) (22) (23) (24) . It is stated that virulent H. pylori strains are not protective against GERD development (25) (26) . In recent prospective researches, it was shown that gastroesophageal refl ux symptoms were ameliorated or pre-existing refl ux esophagitis improved after H. pylori eradication in patients with duodenum ulcer (27) (28) . The geographical differences between distribution of virulent H. pylori strains as well as varying immune response to H. pylori have led to the occurrence of confl icting results in literature (29) . This immune response, which develops subject to Helicobacter pylori, is determined by the virulence of the primary infectious strain, the genetic disposition of the host to the disease and peripheral factors. Certain cytokines such as interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-8 (IL-8), interleukin-10 (IL-10) and tumour necrosis factor (TNF) and interferon (IFN) which are released by the body during the immune response which develops in relation to Helicobacter pylori infection affect different mechanisms and lead to tissue destruction. As a result of the emerging infl ammation, epithelial cell damage leads to various clinical pictures such as atrophia, dysplasia, ulceration and cancer (30) .
The primary genetic factors that affect infl ammatory response to H. pylori are cytokine gene polymorphisms. Polymorphism is a restricted change that may emerge in the DNA chain. Cytokine gene polymorphisms affect the protein structure of and release by the cytokines. Cytokines and cytokine receptor genes have high polymorphism capability. The studies conducted report that cytokine gene polymorphism impact the high mucosal cytokine release, the infl ammatory response and bacterial colonization that develops in the stomach in case of H. pylori infection (31) .
There is a limited number of studies on the effect of cytokine gene polymorphism on H. pylori related diseases. Cytokine gene polymorphism studies dealing with Helicobacter pylori infection frequently concentrate on peptic ulcer and gastric cancer, and increased hypochlorhydria and gastric cancer risk characterized by increase in proinfl ammatory cytokines caused by IL-1α gene polymorphism was shown. Gene polymorphisms, which result in a reduced IL-10 expression, are associated with an increased peptic ulcer and gastric cancer risk. This risk is higher for much virulent H. pylori strains (31) . In this study, we aimed to express the importance of the clinical results that we have obtained as a result of the analysis of Helicobacter pylori virulence genotypes (CagA, VacA, IceA, BabA) and cytokine gene polymorphisms which play an important role in the development of the disease in patients with refl ux esophagitis and peptic ulcer.
Method

Subjects
50 patients who applied to Karadeniz Technical University (KTU) Faculty of Medicine, Gastroenterology Division out-patient clinic with gastrointestinal complaints and diagnosed with refl ux esophagitis and peptic ulcer as a result of physical examination and assessment and upper gastrointestinal endoscopy were enrolled in this study. The blood, biopsy and faeces samples collected from these patients were analyzed in the microbiology laboratory of KTU, Faculty of Medicine. taken antibiotics or any kind of proton pump inhibitors within the eight weeks before admission. This study was performed according to the Declaration of Helsinki. The informed consent was obtained from all patients and research protocols were approved by the Ethics Committee of Karadeniz Technical University Hospital. Two biopsy samples were collected from each corpus and antrum from the patients who were diagnosed with refl ux esophagitis and peptic ulcer as a result of routine physical examination and assessment, and urease, culture and direct microscopy. The rating of refl ux esophagitis was made using Los Angeles classifi cation (32) . For histopathological examination, samples were stained with hematoxylen eosine in the pathology department, and presence of helicobacter pylori was examined. While one of the samples was used to detect urease, other samples were cultivated in Brucella agar for culture. Two laminas were prepared for examination in direct microscopy. Also HpSA antigen was searched for in faeces samples of the same patients. Patients with positive results in any two of the urease, culture, direct microscopy or faeces tests were included in the assessment. Blood (6cc) was collected from these patients in EDTA tubes and mononuclear cells were separated. The cells so separated were stored in -20 °C until DNA isolation. DNA isolation was performed from mononuclear cells. For DNA isolation MagNA Pure LC (Roche) device and MagNA Pure Total Nucleic Acid Isolation Kit (Roche) were used and DNAs obtained. First, the presence of Beta actin gene was investigated in isolated DNAs using PCR, it was determined whether there was suffi cient DNA in the sample, and cytokine gene polymorphism was examined in samples with suffi cient DNA.
Genotyping of cytokine gene polymorphisms
For the genotyping of cytokine gene polymorphism, PCR-SSP (Single Strand Polymorphism) cytokine gene panel of Invitrogen was used (Tab. 1).
For PCR-SSP amplifi cation of each patient a master mix with a total volume of 522.3 μl and a DNA mix (Buffer 140 μl, genomic DNA 50 μl, deionized water 329 μl, Taq Pol. (5 U/μl) 3.3 μl) were prepared. The master mixes prepared were slightly vortexed, and divided into 48 wells on plates in portions of 10 μl and then amplifi ed. The PCR product that was obtained with a 2-minute preliminary denaturation at 94 °C, followed by 10 cycles of denaturation for 15-seconds at 94 °C in the second round, 1 minute of binding at 65 °C, 20 cycles of denaturation for 15 seconds at 94 °C, 50 seconds of binding at 61 °C, and 30 seconds of extension at 72 °C was stored at 4 °C until use. 0.5X TBE-buffer containing 2 % agarose gel was prepared to electrophorese the amplifi ed PCR products. Samples were loaded in 2 separate gels in 24 wells for each patient and were subject to electrophoresis. Results were evaluated in UV transilluminator. It was checked whether the positive controls in each well functioned or not, and wells showing double bands were accepted as positive and photographed.
Polymerase Chain Reaction for cag A, vacA, ice A and babA genes
Samples that multiply in culture were taken to determine bacterial virulence factors and kept in 10 % glycerol-containing brucella liquid medium at -20 °C until use. The biopsies of the samples that did not show any multiplication were kept in 0.9 % NaCl at -20 °C. To obtain H. pylori DNA from these samples, the boiling method was used, and PCR was produced from the DNA obtained using the PCR materials from Promega (Tab. 2).
For the detection of VacA and CagA, 10 mmol/L Tris-HCl (Ph8), 50 mmol/L KCl, 1.5 mmol/L MgCl 2 , deoxynucleotides with a concentration of 200 μmol/L, 25 pmol forward and reverse primers, and 1.5 U Tag DNA polymerase were used for each PCR reaction. Master mixes prepared in specifi ed quantities were slightly vortexed, and divided into small eppendorfs in portions of 40 μl. 10 μl DNA sample was added and amplifi ed.
The PCR program consisted of 3 min of pre-incubation at 95 °C, followed by 38 cycles of 1 min at 95 °C, 1 min at 55 °C for cagA detection or at 50 °C for vacAs and m genotyping, and 1 min at 72 °C. Final extension was performed for 5 min at 72 °C. The PCR products were inspected by electrophoresis on 2 % agarose gels. Water for cell culture grade (Sigma Chemical, UK) was used as negative controls.
For the detection of babA, polymerase chain reactions (PCRs) were performed in a volume of 50 and 25 pmol of specifi c forward and reverse primers. Master mixes prepared in specifi ed quantities were slightly vortexed, and divided into small eppendorfs in portions of 40 μl. 10 μl DNA sample was added and amplifi ed. The PCR program for babA comprised 30 cycles of 1 min at 94 °C, 1 min at 38 °C, and 1 min at 72 °C. After amplifi cation 10 mmol/L of PCR product was electrophoresed on 1.7 % agarose gel and examined under UV illumination.
For Ice A1, IceA2, 10 mmol/L Tris-HCl (Ph8.3), 50 mmol/L KCl, 1.5 mmol/L MgCl 2 , deoxynucleotides with a concentration of 200 μmol/L, 0.5 μM primers, and 2.5 U Tag DNA polymerase were used. The amplifi cation cycles (iceA) consisted of an initial denaturation of target DNA at 94 °C for 9 min and then denaturation at 94 °C for 1 min, primer annealing at 60 °C for 1 min and extension at 72 °C for 1 min (35 cycles). The fi nal cycle included an extension step for 5 min (6, 9, 14 PCR) products were visualised by agarose 2 % gel electrophoresis. 0.5X TBE-buffer containing 2 % agarose gel was prepared and used to electrophorese the amplifi ed PCR products. Results were evaluated in UV transilluminator. Wells that showed bands were accepted as positive and photographed.
Data analysis
The statistical analysis of cytokine gene polymorphism was performed using the SPSS Windows 9.0 program. Statistical signifi cance between the groups were calculated with chi-square test.
The mean values were compared using the Student's t-test. Age, gender and accompanying diseases were evaluated with univariate analysis. p<0.05 value was considered as statistically signifi cant. The ages of the patients varied between 19-70. The mean age of patients with refl ux esophagitis was 41.80±12.98. The mean age of patients with peptic ulcer was 41.56±13.65. When the mean age was examined in both patient groups, no statistical difference was identifi ed (p=0.949). The number of female subjects in refl ux esophagitis group was 13 (52 %) while the number male subjects was 12 (48 %). Number of female subjects in refl ux esophagitis group was 14 (56 %) while the number male subjects was 11 (48 %) . No statistical difference was identifi ed between the two groups in terms of distribution of genders (p=0.777).
Results
This study was carried out between
When body mass indexes of patients with refl ux esophagitis and peptic ulcer were evaluated, BMI was found to be 23.18±3.16 in the patient group with refl ux esophagitis and 23.20±3.54 in the patient group with peptic ulcer. No statistically signifi cant difference was identifi ed between the two groups in terms of body mass index (p=0.832).
When smoking rates were evaluated in patients with refl ux esophagitis and peptic ulcer, number of smokers was found to be 7 in the refl ux esophagitis group and 8 in the peptic ulcer group. No statistically signifi cant difference was identifi ed between the two groups in terms of smoking rate (p=0.758).
None of the patients with refl ux esophagitis and peptic ulcer used corticosteroids, nonsteroidal anti-infl ammatory and anticoagulant agents as a drug.
Findings related to cytokine gene polymorphism in refl ux esophagitis and peptic ulcer patients
When cytokine gene polymorphisms of patients with refl ux esophagitis and peptic ulcer are compared, statistically signifi cant differences were detected with IL-2 -330T +166T (p=0.037) and IL10 -1082A; 819C (p=0.049). IL-2 -330T +166T polymorphism was determined as positive in 2 refl ux esophagitis patients and in 9 peptic ulcer patients. IL10 -1082A; -819C was detected as positive in 18 patients with refl ux esophagitis and in 24 patients with peptic ulcer. When other polymorphisms are viewed, IL-1α -889T, IL-1α -889C, IL-1β -511C, IL-1β -511T, IL-1β +3962T, IL-1β +3962C, IL-1R pst1 1970C, IL-1RA mspa1 11100T, IL-4Ra +1902A, IL-4Rα +1902G, TNF-α -308G; -238G and IL10 -1082G; -819C were detected in both patient groups concurrently with a positivity rate as high as above 80 %. In contrast IL-12 -1188C, TGF-β 10 codonC; 25 codonC, TGF-β 10 codonT; 25 codonC, TNF-α -308A; -238A, IL-2 -330G; +166T, IL-4 -1098G; -590T, IL-4 -1098G; -590C and IL-6 -174G; nt565A were detected in both groups concurrently with a positivity rate below 20 %. In terms of TGF-β 10 codonC; 25 codonC no positivity was detected in any of the two groups (Tab. 3).
Findings related to bacterial virulence factors in refl ux esophagitis and peptic ulcer patients
The fi ndings were obtained by boiling the DNA of the bacteria obtained using the culture method or direct biopsy in patients with refl ux esophagitis and peptic ulcer who proved to be positive in any two of Helicobacter pylori diagnosis tests, and bacterial virulence factors were examined using PCR method (Tab. 4).
CagA, a bacterial virulence factor, was detected as positive in 19 of the patients with refl ux esophagitis (76 %) and in 18 of the patients with peptic ulcer (72 %). No statistical difference was identifi ed between the two patient groups in terms of CagA as a virulence factor (p=1.000).
VacA, a H. pylori virulence factor, is divided into two as s1ve s2 as a signal sequence. S1 is separated into three as s1a, s1b and s1c. s1 and s2 were detected as positive in respectively 19 (76 %) and 6 (24 %) of the patients with refl ux esophagitis, whereas s1 and s2 were detected as positive in respectively 20 (80 %) and 5 (20 %) of the patients with peptic ulcer. 19 of the patients with refl ux esophagitis (76 %) and 20 of the patients with peptic ulcer (80 %) in who S1 was detected were found to have s1a. 6 of the patients with refl ux esophagitis (24 %) and 5 of the patients with peptic ulcer (20 %) in who S1 was detected were found to have sb1. S1c was not detected as positive in any of the patients. No statistical difference was detected between the two groups in terms of s1, s1a, s1b, and s2 (p=0.733).
When we examined IceA1 and IceA2 virulence factors, IceA1 was detected as positive in 10 of the patients with refl ux esophagitis (40 %) and in 8 of the patients with peptic ulcer (32 %). In the case of IceA2 positivity was detected in 7 of the patients with refl ux esophagitis (28 %) and in 6 of the patients with peptic ulcer (24 %). From the results obtained, no statistically signifi cant difference was determined between the two patient groups (IceA1 p=0,556, IceA2 p=0,747). BabA positivity rate was detected in 13 of the patients with refl ux esophagitis (52 %) and in 14 of the patients with peptic ulcer (56 %), however this result is not statistically signifi cant (p=1.000).
Discussion
Helicobacter pylori is a gram-negative microorganism that may lead to various diseases such as chronic gastritis, peptic ulcer, mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer. A majority of the people infected with Helicobacter pylori is asymptomatic, but the above mentioned diseases can be seen in up to 15-20 % of this population. Basic factors that play a role in the development of diseases associated with Helicobacter pylori are specifi c virulence factors, genetic factors of the host and peripheral factors (33) .
In this study, which we conducted on patients with peptic ulcer and gastroesophageal refl ux, infected with Helicobacter pylori, we aimed to assess the basic factors that were thought to play a role in the development of the disease. For this reason, use of drugs, smoking and body mass index were evaluated as peripheral factors. VacA, CagA, BabA and Ice A virulence genotypes, which are the specifi c virulence factors of the bacterium were studied with cytokine gene polymorphisms of IL-1, IL-2, IL-4, IL-6, IL-10, IL-12, interferon-γ, TNF-α, and TGF-β1 that are known to affect the immune response in the patients.
CagA positivity was detected as 76 % in the refl ux esophagitis group, 72 % in the peptic ulcer group, and 74 % as average when all patients are taken together. In studies conducted in our country, cagA positivity is reported to be in the range of 59 % and 78 %. Various studies conducted show that cagA positivity is associated with peptic ulcer formation. In a study conducted by Aydin et al. in our country, it was reported that cagA positivity was associated with an increased duodenal ulcer and gastric cancer risk (34) . In another study performed by Leodolter et al, cagA positivity was detected to be higher in patients with duodenal ulcer and GERD than in patients with functional dyspepsia (respectively, 40 %, 83 %, 80 %), and this result was similar to our data (26) .
VacA, a H. pylori virulence factor, is divided into two subtypes as s1ve s2 as a signal sequence. In our study, no statistically signifi cant was detected in terms of vacA s1, vacA s1a, vacA s1b and vacA s1c and vacA s2 between the two groups with refl ux esophagitis and peptic ulcer (p=0.733). S1c was not detected as positive in any of the patients.
When all patients are evaluated together, iceA1 was detected in the rate of 36 %, iceA2 was detected in the rate of 26 %. Erzin et al on patients with dyspepsia, iceA1 was determined as 74.7 and IceA2 as 25.3 %, iceA1 rates in our region were found to be lower than in Istanbul. However, iceA1 is much dominant compared to iceA2 in our country, and is consistent with Holland (35), Japan (36) and Hong Kong (37) fi ndings. Studies conducted in USA (38) , Columbia (39) and Brazil showed that iceA2 was dominant (40) . Peek et al (41) and van Doorn et al (35) reported meaningful association between iceA1 genotype and peptic ulcer, and no statistically signifi cant difference was found in our study between the two groups with refl ux esophagitis and peptic ulcer in terms of iceA1 and iceA2 (IceA1 p=0,556, IceA2 p=0,747).
BabA was detected as positive in 13 of the patients with refl ux esophagitis (52 %) and in 14 of the patients with peptic ulcer (56 %). The mean babA positivity was reported as 52.5 %, similar to babA positivity in our study which was detected as 54 % in a study in Turkey (42) . In our study no statistically signifi cant difference was found between the two groups with refl ux esophagitis and peptic ulcer in terms of babA, and a babA positivity of average 54 % was detected (p=1.000).
In this study, where we assessed refl ux esophagitis and peptic ulcer patients in terms of bacterial virulence genotypes, it was found that the subjects expressed multi Helicobacter pylori virulence genotypes (cagA, vacA, babA). Similar to our fi ndings, in the study performed by Leodolter et al, cagA, vacA, and babA positivity was shown to be higher in patients with duodenal ulcer and gastroesophageal refl ux disease than in patients with functional dyspepsia. The literature stresses the importance of multi virulence genotype expression, which increases infl ammation and plays role in the development of diseases associated with Helicobacter pylori (43) .
In this study, we have performed in the East Black Sea Region, the results we have achieved in terms of expression rates of virulence genotypes show similarity to studies conducted in other regions of our country.
Cytokines are regulators of host immune response in situations such as infection, infl ammation and trauma. In such situations, some cytokines increase infl ammation and are called proinfl ammatory cytokines. Primary proinfl ammatory cytokines are IL-1, IL-2, TNFα, IL-6, IL-8, IL-11, IL-12 and chemokines. Some cytokines are responsible for suppressing proinfl ammatory cytokine activity. These are called anti-infl ammatory cytokines. Primary anti-infl ammatory cytokines are IL-4, IL-10, IL-13, IL-16, IFN-α.
Studies on cytokine polymorphisms associated with Helicobacter pylori frequently focus on gastric cancer, and increased risk of hypochlorhydria and gastric cancer characterized with increase in proinfl ammatory cytokines as a result of IL-1β gene polymorphism was shown (44) . Predisposition to increased gastric atrophia and gastric cancer associated with IL-2 gene polymorphism has been reported in the literature. Won HH et al reported that interleukin 10 polymorphisms differentially infl uence the risk of gastric cancer in East Asians and Caucasians. There is a limited number of studies relating to gastroesophageal refl ux disease and cytokine gene polymorphism. Muramatsu et al reported increased IL-1β-511C/T polymorphism in patients with refl ux esophagitis (40) .
In this study, that we have conducted on patients with refl ux esophagitis and peptic ulcer, IL-2 -330T +166T polymorphism was determined as positive in 9 peptic ulcer patients and only in 2 refl ux esophagitis patients. IL-2 T/T polymorphism was much frequently detected in patients with peptic ulcer than in patients with refl ux esophagitis, and this difference was found to be statistically signifi cant (p=0.037).
T cell response, which develops in subject to Helicobacter pylori, is dominantly seen as T helper 1 (Th1) response in humans (46) . Th1 cells produce IL-2 and such responses are associated with the expression of proinfl ammatory cytokines such as IFN-γ and TNF-α. IL-2 is a strong proinfl ammatory cytokine. Macrophages secrete proinfl ammatory factors when induced by Th1 cells. IL-2 induces antibody production with the proliferation of active T and B cells. They induce IL-3, IL-4, IL-5, IL-6, GM-CSF, INF-γ, TNF-β and TGF-β syntheses. Cytotoxic T lymphocytes ensure the activation of NK cells and neutrophils. Increased IL-2 inhibits gastric acid secretion with Th1 response, and results in precancerous gastric atrophia, metaplasia and dysplasia. In their study, Togawa et al determined thrice increase in gastric atrophia prevalence in 2T/T genotype compared to IL 2G/G genotype47. Increased IL-2 T/T cytokine gene polymorphism we have determined in patients with peptic ulcer in this study is supported by immunologic evidences, which play a role in peptic ulcer development.
In our study, IL10 -1082A; -819C polymorphism was detected as positive in 18 patients with refl ux esophagitis and in 24 patients with peptic ulcer. IL-10 -1082A; -819C polymorphism was slightly much more detected in patients with peptic ulcer than in patients with refl ux esophagitis, and this difference was found to be statistically signifi cant (p=0.049).
IL-10 is a multi-functional anti-infl ammatory cytokine. IL-10 is secreted from Th 2 cells, thymocytes, monocytes, macrophages, B cells and Langerhans cells. Th 1 helps to suppress cell response and inhibit IL-2 and IFN synthesis. IL-10 induces B cell proliferation and differentiation. It inhibits IL-1, IL-6, IL-8, GM-CSF, G-CSF synthesis, suppresses infl ammation and has a suppressive effect on type Th1 immune response. Low IL-10 production in patients infected with Helicobacter pylori results in increased gastric infl ammation intensity, hypochlorhydria and increased risk of gastric atrophia and gastric cancer. Lu et al (48) reported increased risk of gastric cancer and peptic ulcer associated with IL-10 gene polymorphism. In another study conducted by El-Omar, it is stated that anti-infl ammatory cytokines such as IL-10 have two-fold more effect in the formation of extracardiac gastric cancer (44) .
In conclusion, this preliminary study establishes the importance of multi bacterial virulence factors and the cytokine gene polymorphisms that shape the immune response in the host on the development of peptic ulcer in patients with refl ux esophagitis and peptic ulcer, infected with Helicobacter pylori. It was found that the subjects with refl ux esophagitis and peptic ulcer expressed multi Helicobacter pylori virulence genotypes (cagA, vacA, iceA). In Turkey, H. pylori infection caused by these multi genotypes are much prevalent compared to western countries (49) (50) . This result may be related to a wide prevalence of H. pylori and childhood infections in Turkey. H. pylori may undergo genetic changes during the long-term colonization starting from the childhood (51). It was concluded that prevalence of multi-strain colonization should be taken into account when planning treatment and also researches relating to the pathogenesis of H. pylori infection.
IL-2 T/T polymorphism and IL-10 -1082A; -819C polymorphism, which was detected in patients with peptic ulcer, are considered to have an effect on peptic ulcer formation.
As a result, consistent with literature, multi Helicobacter pylori virulence genotype expression was found to be important in the development of diseases associated with Helicobacter pylori. However, it was concluded that cytokine gene polymorphisms may also play a role in peptic ulcer development. It is considered that a detection of multi virulence genotype expression and cytokine gene polymorphism may provide guidance in detecting prognosis in patients infected with Helicobacter pylori in studies to be conducted in the future years.
Which clinical pictures of Helicobacter pylori will result is determined primarily by the bacterial virulence factors and the immune system of the host, and it has been concluded that broadscale meta-analyses will be required where HLA tissue groups, infl ammation mediators, parietal cell antibodies, acid secretion and infection age, which were shown to infl uence this result have to be evaluated together.
